Department of Orthopedics and Traumatology, Gaziantep University Faculty of Medicine, Gaziantep-Türkiye.
Department of Orthopedics and Traumatology, Şehitkamil State Hospital, Gaziantep-Türkiye.
Ulus Travma Acil Cerrahi Derg. 2022 Sep;28(9):1323-1327. doi: 10.14744/tjtes.2021.45843.
This study aimed to investigate intravenous tranexamic acid's (TA) effect on blood loss and transfusion ratios in pelvis-acetabulum fractures treated with open reduction and internal fixation.
Patients who underwent open reduction and internal fixation due to pelvis-acetabulum fractures between January 2017 and January 2019 constituted this study's target population. After applying inclusion and exclusion criteria, patients were divided into two groups: Those who were perioperatively given 15 mg/kg TA (i.e., Group 1) and those who were not (i.e., Group 2). Data including age, gender, mechanism of injury, fracture type, presence or absence of additional injuries, the time interval between admission and surgery, incision site, pre-operative and post-operative hemoglobin levels, intraoperative estimated blood loss (EBL), number of blood units transfused, and complications were recorded. Two groups were compared regarding these parameters.
The study cohort included 58 patients. There were 30 patients in Group 1 and 28 patients in Group 2. Our analysis revealed that the number of blood units transfused was significantly higher in Group 2 than Group 1 (p=0.016). However, there was no significant difference between the two groups regarding intraoperative EBL, pre-operative and post-operative hemoglobin levels, and the time interval between admission and surgery.
Administration of intravenous TA reduces blood transfusion requirement in patients with pelvis-acetabulum fractures treated with open reduction and internal fixation. This approach can prevent potential blood transfusion-related complications.
本研究旨在探讨静脉注射氨甲环酸(TA)对骨盆髋臼骨折切开复位内固定治疗中失血量和输血比例的影响。
本研究的目标人群为 2017 年 1 月至 2019 年 1 月期间因骨盆髋臼骨折接受切开复位内固定的患者。应用纳入和排除标准后,将患者分为两组:围手术期给予 15mg/kg TA 的患者(即组 1)和未给予 TA 的患者(即组 2)。记录包括年龄、性别、损伤机制、骨折类型、是否合并其他损伤、入院至手术时间间隔、切口部位、术前和术后血红蛋白水平、术中估计失血量(EBL)、输血量和并发症在内的数据。比较两组患者的上述参数。
本研究共纳入 58 例患者。组 1 有 30 例,组 2 有 28 例。我们的分析表明,组 2 的输血量明显高于组 1(p=0.016)。然而,两组患者的术中 EBL、术前和术后血红蛋白水平以及入院至手术时间间隔均无显著差异。
在接受切开复位内固定治疗的骨盆髋臼骨折患者中,静脉注射 TA 可减少输血需求,预防潜在的输血相关并发症。